Discover 42 paid clinical trials in Gulfport, Mississippi. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 42
Featured
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
for
Obesity or Overweight
Location: Gulfport MS, New Orleans LA, Birmingham AL, Anniston AL,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07351045
Phase3, Recruiting
Active & Responsive
STRIVE Post-Market Registry Study
for
Emphysema
Location: Gulfport MS, Shreveport LA, Anderson SC, Dallas TX,
Sponsor: Olympus Corporation of the Americas
Sex: All
Age: 18+
Code: NCT04302272
Recruiting
Active & Responsive
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
for
Hypertension
Location: Gulfport MS, New Orleans LA, Houma LA, Pensecola FL,
Sponsor: SoniVie Inc.
Sex: All
Age: 22 - 70+
Code: NCT06559891
Recruiting
Active & Responsive
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
for
Lung Cancer Diagnosis
Location: Gulfport MS, Jackson TN, Tyler TX, Gainesville GA,
Sponsor: Freenome Holdings Inc.
Sex: All
Age: 50+
Code: NCT06122077
Recruiting
Active & Responsive
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
Get alerts for new trials in your area by subscribing now
Active & Responsive
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
for
Cardiovascular Disease
Location: Slidell LA, Mobile AL, Daphne AL, Fairhope AL,
Sponsor: Amgen
Sex: All
Age: 50 - 70+
Code: NCT07136012
Phase3, Recruiting
Active & Responsive
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Location: Mobile AL, Daphne AL, Covington LA, Marrero LA,
Sponsor: Amgen
Sex: All
Age: 45 - 70+
Code: NCT07037433
Phase3, Recruiting
Active & Responsive
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
for
Irritable Bowel Syndrome
Location: Mobile AL, Jackson MS, Birmingham AL, Shreveport LA,
Sponsor: Dynogen Pharmaceuticals
Sex: Female
Age: 18 - 65
Code: NCT00547469
Phase2, Phase3, Recruiting
Active & Responsive
Caris Biorepository Research Protocol
for
Cancer, Early Detection of Cancer, Minimal Residual Disease
Location: Mobile AL, Hattiesburg MS, New Orleans LA, Jackson MS,
Sponsor: Caris Science, Inc.
Sex: All
Age: 18+
Code: NCT01499394
Recruiting
Active & Responsive
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
for
Cancer, Metastatic, Cancer, Cancer of Pancreas, Cancer of Liver,
Location: Hattiesburg MS, Mobile AL, Birmingham AL, Memphis TN,
Sponsor: Massive Bio, Inc.
Sex: All
Age: 0+
Code: NCT03452774
Recruiting
Statewide Optimization of Lung Cancer Screening Utilizing the QUILS™ System in Nevada and Mississippi: State-Based Initiative Component
for
Lung Cancer Screening
Location: Gulfport MS, Hattiesburg MS, Jackson MS, Greenwood MS,
Sponsor: Timothy Mullett
Sex: All
Age: 18 - 70+
Code: NCT07682597
Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
for
Advanced Malignant Solid Neoplasm,
Location: Gulfport MS, Mobile AL, New Orleans LA, Metairie LA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0+
Code: NCT05564377
Phase2, Recruiting
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: Gulfport MS, New Orleans LA, Metairie LA, Birmingham AL,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT04510597
Phase3, Recruiting
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Gulfport MS, Newnan GA, Germantown TN, The Woodlands TX,
Sponsor: Loxo Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06588478
Phase2, Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
for
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma,
Location: Gulfport MS, Little Rock AR, Fort Smith AR,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT04566328
Phase3, Recruiting
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Gulfport MS, Mobile AL, Daphne AL, Saraland AL,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06616584
Phase2, Phase3, Recruiting
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)